Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections.

Immunology: Bioinformatics Molecular Biology Transcriptomics

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
22 Jan 2021
Historique:
received: 10 07 2020
revised: 11 11 2020
accepted: 11 12 2020
entrez: 13 1 2021
pubmed: 14 1 2021
medline: 14 1 2021
Statut: epublish

Résumé

The pandemic 2019 novel coronavirus disease (COVID-19) shares certain clinical characteristics with other acute viral infections. We studied the whole-blood transcriptomic host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using RNAseq from 24 healthy controls and 62 prospectively enrolled patients with COVID-19. We then compared these data to non-COVID-19 viral infections, curated from 23 independent studies profiling 1,855 blood samples covering six viruses (influenza, respiratory syncytial virus (RSV), human rhinovirus (HRV), severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1), Ebola, dengue). We show gene expression changes in COVID-19 versus non-COVID-19 viral infections are highly correlated (r = 0.74, p < 0.001). However, we also found 416 genes specific to COVID-19. Inspection of top genes revealed dynamic immune evasion and counter host responses specific to COVID-19. Statistical deconvolution of cell proportions maps many cell type proportions concordantly shifting. Discordantly increased in COVID-19 were CD56

Identifiants

pubmed: 33437935
doi: 10.1016/j.isci.2020.101947
pii: S2589-0042(20)31144-5
pmc: PMC7786129
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101947

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

S.A.T., Y.D.H., Y.H., S.S., R.P., D.R., M.R., S.C., and T.E.S. are employees of and stockholders in Inflammatix, Inc. P.K. reports being a shareholder and a consultant to Inflammatix, Inc. E.J.G.B. reports receiving honoraria from 10.13039/100006483AbbVie 10.13039/100011408USA, Abbott CH, InflaRx GmbH, MSD Greece, XBiotech Inc., and 10.13039/501100006546Angelini Italy; independent educational grants from 10.13039/100006483AbbVie, Abbott, 10.13039/501100006044Astellas Pharma Europe, AxisShield, bioMérieux Inc, InflaRx GmbH, and XBiotech Inc; and funding from the FrameWork 7 program HemoSpec (granted to the National and Kapodistrian University of Athens), the 10.13039/501100007601Horizon 2020 Marie-Curie Project European Sepsis Academy (granted to the National and Kapodistrian University of Athens), and the 10.13039/501100007601Horizon 2020 European Grant ImmunoSep (granted to the Hellenic Institute for the Study of Sepsis). The other authors declare no competing interests.

Références

Cell. 2020 Sep 3;182(5):1077-1092
pubmed: 32846157
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Cytokine Growth Factor Rev. 2020 Jun;53:66-70
pubmed: 32418715
Cell Host Microbe. 2020 Jul 8;28(1):117-123.e1
pubmed: 32411313
JCI Insight. 2020 Feb 27;5(4):
pubmed: 31971918
Haematologica. 2017 May;102(5):809-817
pubmed: 28280078
Proc Natl Acad Sci U S A. 1989 May;86(10):3574-8
pubmed: 2498873
Immunity. 2015 Dec 15;43(6):1199-211
pubmed: 26682989
Eur J Epidemiol. 2020 Aug;35(8):763-773
pubmed: 32816244
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
JAMA Netw Open. 2018 Oct 5;1(6):e183779
pubmed: 30646264
J Virol. 2008 Dec;82(23):11486-94
pubmed: 18787005
J Med Virol. 2020 Oct;92(10):1733-1734
pubmed: 32242950
Nucleic Acids Res. 2017 Jan 9;45(1):e1
pubmed: 27634930
Nat Commun. 2018 Feb 15;9(1):694
pubmed: 29449546
Cold Spring Harb Perspect Biol. 2013 Jan 01;5(1):a013250
pubmed: 23284050
Cell Host Microbe. 2016 Nov 9;20(5):654-665
pubmed: 27773535
J Leukoc Biol. 2020 Jul;108(1):17-41
pubmed: 32534467
Cell Rep Med. 2020 Aug 25;1(5):100078
pubmed: 32838342
J Exp Med. 2013 Oct 21;210(11):2205-21
pubmed: 24127489
J Clin Cell Immunol. 2015 Apr;6(2):
pubmed: 26213635
Curr Opin Rheumatol. 2002 Sep;14(5):548-52
pubmed: 12192253
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
Pac Symp Biocomput. 2016;22:144-153
pubmed: 27896970
Sci Rep. 2018 Jan 22;8(1):1362
pubmed: 29358745
Am J Transplant. 2012 Oct;12(10):2710-8
pubmed: 23009139
J Transl Med. 2020 May 20;18(1):206
pubmed: 32434518
J Nutr Biochem. 2016 Aug;34:1-7
pubmed: 27424223
Hong Kong Med J. 2012 Feb;18 Suppl 2:31-6
pubmed: 22311359
Pediatr Res. 1996 Feb;39(2):191-8
pubmed: 8825786
Sci Rep. 2018 Mar 23;8(1):5115
pubmed: 29572502
Nat Commun. 2014 Jun 20;5:4207
pubmed: 24947469
Biochem Mol Biol Educ. 2006 Sep;34(5):395
pubmed: 21638727
Signal Transduct Target Ther. 2020 May 29;5(1):84
pubmed: 32467561
Crit Care Med. 2018 Jun;46(6):915-925
pubmed: 29537985
JCI Insight. 2020 Sep 3;5(17):
pubmed: 32706339
Nat Commun. 2020 Mar 4;11(1):1177
pubmed: 32132525
Nat Rev Microbiol. 2008 Jul;6(7):541-52
pubmed: 18552864
Nature. 2020 Apr;580(7805):576-577
pubmed: 32346146
Sci Transl Med. 2017 Jan 11;9(372):
pubmed: 28077676
Cell Rep. 2018 Jun 5;23(10):3042-3055
pubmed: 29874589
Clin Chim Acta. 2020 Aug;507:174-180
pubmed: 32339487
PLoS Pathog. 2011 Dec;7(12):e1002433
pubmed: 22174690
Emerg Infect Dis. 2004 Apr;10(4):581-6
pubmed: 15200845
Front Immunol. 2020 May 01;11:827
pubmed: 32425950
J Cell Biol. 2003 Mar 17;160(6):963-73
pubmed: 12629050
ACS Infect Dis. 2016 May 13;2(5):361-76
pubmed: 27627203
Lancet Respir Med. 2016 Mar;4(3):213-24
pubmed: 26907218
Nature. 2007 Oct 18;449(7164):819-26
pubmed: 17943118
Nat Microbiol. 2019 Jun;4(6):914-924
pubmed: 30936491
J Immunol. 2008 Sep 15;181(6):3733-9
pubmed: 18768823
J Virol. 2019 Nov 13;93(23):
pubmed: 31534046
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Kidney Int. 2020 Jul;98(1):235-236
pubmed: 32471636
Mol Cell. 2018 Mar 15;69(6):1028-1038.e6
pubmed: 29547716
Dev Cell. 2018 Oct 8;47(1):122-132.e4
pubmed: 30220567
J Cell Biol. 2012 Jun 11;197(6):697-709
pubmed: 22689651
Cancer Res. 2014 May 15;74(10):2892-902
pubmed: 24654231
Front Immunol. 2020 Aug 07;11:1949
pubmed: 32849654
Nat Immunol. 2008 May;9(5):503-10
pubmed: 18425107
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
J Biol Chem. 2019 Sep 27;294(39):14406-14421
pubmed: 31399512
Psychol Methods. 2001 Sep;6(3):203-17
pubmed: 11570228
Sci Transl Med. 2016 Jul 6;8(346):346ra91
pubmed: 27384347
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Viral Immunol. 2012 Aug;25(4):277-88
pubmed: 22876772
Lancet Infect Dis. 2014 Nov;14(11):1090-1095
pubmed: 25278221
Sci Transl Med. 2015 May 13;7(287):287ra71
pubmed: 25972003
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1260-1
pubmed: 26568247

Auteurs

Simone A Thair (SA)

Inflammatix, Inc., 863 Mitten Road, Suite 104, Burlingame, CA 94010, USA.

Yudong D He (YD)

Inflammatix, Inc., 863 Mitten Road, Suite 104, Burlingame, CA 94010, USA.

Yehudit Hasin-Brumshtein (Y)

Inflammatix, Inc., 863 Mitten Road, Suite 104, Burlingame, CA 94010, USA.

Suraj Sakaram (S)

Inflammatix, Inc., 863 Mitten Road, Suite 104, Burlingame, CA 94010, USA.

Rushika Pandya (R)

Inflammatix, Inc., 863 Mitten Road, Suite 104, Burlingame, CA 94010, USA.

Jiaying Toh (J)

Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Palo Alto, CA 94305, USA.
Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA 94305, USA.

David Rawling (D)

Inflammatix, Inc., 863 Mitten Road, Suite 104, Burlingame, CA 94010, USA.

Melissa Remmel (M)

Inflammatix, Inc., 863 Mitten Road, Suite 104, Burlingame, CA 94010, USA.

Sabrina Coyle (S)

Inflammatix, Inc., 863 Mitten Road, Suite 104, Burlingame, CA 94010, USA.

George N Dalekos (GN)

Department of Internal Medicine, University of Thessaly, Larissa General Hospital, Greece.

Ioannis Koutsodimitropoulos (I)

Intensive Care Unit, Latseion General Hospital of Elefsis, Greece.

Glykeria Vlachogianni (G)

Intensive Care Unit, Aghios Dimitrios Thessaloniki General Hospital, Greece.

Eleni Gkeka (E)

Intensive Care Unit, AHEPA Thessaloniki General Hospital, Greece.

Eleni Karakike (E)

4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece.

Georgia Damoraki (G)

4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece.

Nikolaos Antonakos (N)

4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece.

Purvesh Khatri (P)

Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Palo Alto, CA 94305, USA.
Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA 94305, USA.

Evangelos J Giamarellos-Bourboulis (EJ)

4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece.

Timothy E Sweeney (TE)

Inflammatix, Inc., 863 Mitten Road, Suite 104, Burlingame, CA 94010, USA.

Classifications MeSH